Perched on the cliffs of Torrey Pines, investors, CEOs, and scientists this week debated whether U.S. biotechs are losing ground to China. Meanwhile, across the Pacific, Chinese companies were busy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results